APA (7th ed.) Citation

Welén, K., Överby, A. K., Ahlm, C., Freyhult, E., Robinsson, D., Henningsson, A. J., . . . Josefsson, A. (2021). COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): A structured summary of a study protocol for a randomised controlled trial. Current controlled trials in cardiovascular medicine, 22(1), 209-3. https://doi.org/10.1186/s13063-021-05137-4

Chicago Style (17th ed.) Citation

Welén, Karin, et al. "COVIDENZA - A Prospective, Multicenter, Randomized PHASE II Clinical Trial of Enzalutamide Treatment to Decrease the Morbidity in Patients with Corona Virus Disease 2019 (COVID-19): A Structured Summary of a Study Protocol for a Randomised Controlled Trial." Current Controlled Trials in Cardiovascular Medicine 22, no. 1 (2021): 209-3. https://doi.org/10.1186/s13063-021-05137-4.

MLA (9th ed.) Citation

Welén, Karin, et al. "COVIDENZA - A Prospective, Multicenter, Randomized PHASE II Clinical Trial of Enzalutamide Treatment to Decrease the Morbidity in Patients with Corona Virus Disease 2019 (COVID-19): A Structured Summary of a Study Protocol for a Randomised Controlled Trial." Current Controlled Trials in Cardiovascular Medicine, vol. 22, no. 1, 2021, pp. 209-3, https://doi.org/10.1186/s13063-021-05137-4.